Wave Life Sciences Ltd.

NASDAQ:WVE

10.81 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 83.748-7.67619.69212.53829.05649.21422.10612.9291.2390.2850.3751.751.76536.4232.77609.4393.453.0274.1612.42.9297.6283.0263.624.4934.8791.4221.6760.6760.6760.6760.6760.3920.41700.15200.1260.0260000
Cost of Revenue 0040.3932.1772.1822.2642.3222.4382.4952.60129.73327.4725.76131.08631.6352.4623.25428.27531.47841.15849.12844.58541.60540.11339.80932.87632.54729.19625.36920.09719.10314.7413.99513.6868.4014.7363.4682.1321.851.6070.7230.5850.5440.544
Gross Profit 83.748-7.676-20.70110.36126.87446.9519.78410.491-1.256-2.316-29.358-25.72-23.9965.337-28.859-2.46-13.815-24.825-28.451-36.997-46.728-41.656-33.977-37.087-36.189-28.383-27.668-27.774-23.693-19.421-18.427-14.064-13.319-13.294-7.984-4.736-3.316-2.132-1.724-1.581-0.723-0.585-0.544-0.544
Gross Profit Ratio 11-1.0510.8260.9250.9540.8950.811-1.014-8.126-78.288-14.697-13.5950.147-10.3960-1.464-7.196-9.399-8.891-19.47-14.222-4.454-12.256-9.997-6.317-5.671-19.532-14.137-28.729-27.259-20.805-19.703-33.913-19.1460-21.8160-13.683-60.8080000
Reseach & Development Expenses 44.64541.19740.39333.44734.07431.64233.31430.97931.07827.57529.73327.4725.76131.08631.63533.39330.03328.27531.47841.15849.12844.58541.60540.11339.80932.87632.54729.19625.36920.09719.10314.7413.99513.6868.4014.7363.4682.1321.851.6070.7230.5850.5440.544
General & Administrative Expenses 16.13615.04214.29613.54913.66413.12812.26512.23513.72411.60912.80612.37412.11412.94410.96910.0789.7199.5910.20512.99613.80512.52311.6410.90112.7549.8498.9058.0016.8877.5716.6675.855.1853.9393.6543.2163.7462.8581.9051.8841.0570.7690.5870.587
Selling & Marketing Expenses 000-2.177-2.182000000000000000000000000000000000000000
SG&A 16.13615.04214.29611.37211.48213.12812.26512.23513.72411.60912.80612.37412.11412.94410.96910.0789.7199.5910.20512.99613.80512.52311.6410.90112.7549.8498.9058.0016.8877.5716.6675.855.1853.9393.6543.2163.7462.8581.9051.8841.0570.7690.5870.587
Other Expenses 0000.3650.5820.1710.1181.007-0.29-0.7010.7440.2541.1161.3711.0540.9960.6591.292-2.0052.1123.0232.2392.1232.3539.933-0.468-0.2590.343-0.12-0.075-0.064-0.072-0.025-0.0360.015-0.004-0.0990.112-0.0070.050.0210.02500
Operating Expenses 60.78156.23954.68944.81945.55644.7745.57943.21444.80239.18442.53939.84437.87544.0342.60443.47139.75237.86541.68354.15462.93357.10853.24551.01452.56342.72541.45237.19732.25627.66825.7720.5919.1817.62512.0557.9527.2144.993.7553.4911.781.3540.4790.479
Operating Income 22.967-63.915-34.997-34.458-18.6824.444-23.473-30.285-43.563-38.899-42.164-38.094-36.11-7.607-39.828-43.471-30.313-34.415-38.656-49.993-60.533-54.179-45.617-47.988-48.943-38.232-36.573-35.775-30.58-26.992-25.094-19.914-18.504-17.233-11.638-7.952-7.214-4.99-3.629-3.465-1.78-1.354-1.13-1.13
Operating Income Ratio 0.2748.327-1.777-2.748-0.6430.09-1.062-2.342-35.16-136.488-112.437-21.768-20.459-0.209-14.3470-3.211-9.975-12.77-12.015-25.222-18.497-5.98-15.859-13.52-8.509-7.496-25.158-18.246-39.929-37.121-29.459-27.373-43.962-27.9090-47.4610-28.802-133.2690000
Total Other Income Expenses Net 6.2862.1352.0742.92.4262.1312.3692.880.535-0.1050.8680.281.1211.3771.0621.0070.6831.315-1.8722.53.7633.4533.6753.78810.9530.6010.6790.7060.1720.4410.4190.2210.2390.0820.1210.1-0.0230.137-0.0220.050.0210.0250.1020.102
Income Before Tax 29.253-61.78-32.923-31.558-16.2566.575-21.104-27.405-43.028-39.004-41.296-37.814-34.989-6.23-38.766-42.464-29.63-33.1-40.528-47.493-56.77-50.726-41.942-44.2-37.99-37.631-35.894-35.069-30.408-26.551-24.675-19.693-18.265-17.151-11.517-7.852-7.237-4.853-3.651-3.415-1.759-1.329-1.029-1.029
Income Before Tax Ratio 0.3498.048-1.672-2.517-0.5590.134-0.955-2.12-34.728-136.856-110.123-21.608-19.824-0.171-13.9650-3.139-9.594-13.389-11.414-23.654-17.319-5.498-14.607-10.494-8.375-7.357-24.662-18.143-39.277-36.501-29.132-27.019-43.753-27.6190-47.6120-28.976-131.3460000
Income Tax Expense 000-07.4530.677-4.573-2.880.6810.105-41.42-0.28-0.204-0.006-0.008-0.011-0.841-2.533-0.133-0.388-3.17-1.214-3.801-3.599-0.103-1.069-0.9380.172-0.197-0.4160.0181.3030.1890.3840.048-0.005-0.1380.0830.0490.05-0.010.0340.030.03
Net Income 29.253-61.78-32.923-31.558-16.2567.252-21.104-24.525-43.709-39.1090.124-37.534-34.785-6.23-38.766-42.464-28.789-33.1-40.528-47.493-56.77-50.726-41.942-44.2-37.887-37.631-35.894-35.241-30.211-26.135-24.693-20.996-18.454-17.535-11.565-7.847-7.099-4.936-3.7-3.465-1.749-1.363-1.059-1.059
Net Income Ratio 0.3498.048-1.672-2.517-0.5590.147-0.955-1.897-35.278-137.2250.331-21.448-19.708-0.171-13.9650-3.05-9.594-13.389-11.414-23.654-17.319-5.498-14.607-10.466-8.375-7.357-24.783-18.026-38.661-36.528-31.059-27.299-44.732-27.7340-46.7040-29.365-133.2690000
EPS 0.18-0.47-0.25-0.24-0.150.066-0.2-0.24-0.47-0.420.002-0.62-0.61-0.12-0.78-0.86-0.59-0.86-1.15-1.38-1.65-1.48-1.22-1.36-1.16-1.28-1.23-1.26-1.09-0.94-0.92-0.89-0.79-0.75-0.51-0.36-0.33-0.25-0.18-0.17-0.084-0.065-0.3-0.3
EPS Diluted 0.17-0.47-0.25-0.24-0.150.065-0.2-0.24-0.47-0.420.002-0.62-0.61-0.12-0.78-0.86-0.59-0.86-1.15-1.38-1.65-1.48-1.22-1.36-1.16-1.28-1.23-1.26-1.08-0.94-0.92-0.89-0.78-0.75-0.51-0.36-0.33-0.25-0.18-0.17-0.084-0.065-0.3-0.3
EBITDA 25.123-61.757-32.825-32.281-16.56.708-21.151-27.847-40.533-36.403-38.792-35.3-32.451-5.21-36.326-40.004-27.12-31.905-36.632-47.954-58.529-52.232-43.763-46.205-47.229-36.774-35.339-34.6-29.519-25.758-24.317-19.892-18.245-17.045-11.454-7.799-7.082-4.706-3.54-3.376-1.433-1.263-1.078-1.078
EBITDA Ratio 0.38.045-1.667-2.575-0.5680.09-1.164-2.299-35.16-129.453-106.091-20.346-20.462-0.143-13.4710-3.214-9.987-11.995-11.511-25.529-18.105-6.183-16.329-13.327-8.422-7.435-24.582-17.889-39.811-37.308-29.422-26.99-43.482-27.9090-46.5920-28.095-129.8460000